KalVista Pharmaceuticals (KALV) Share-based Compensation (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 47.69% |
| Oct 31, 2024 | -1.35% |
| Jul 31, 2024 | 38.18% |
| Apr 30, 2024 | -18.85% |
| Jan 31, 2024 | -15.47% |
| Oct 31, 2023 | -1.44% |
| Jul 31, 2023 | 33.31% |
| Apr 30, 2023 | 4.63% |
| Jan 31, 2023 | -6.90% |
| Oct 31, 2022 | -5.15% |
| Jul 31, 2022 | -0.45% |
| Apr 30, 2022 | -4.43% |
| Jan 31, 2022 | -2.90% |
| Oct 31, 2021 | 2.33% |
| Jul 31, 2021 | -18.77% |
| Apr 30, 2021 | 177.28% |
| Jan 31, 2021 | -0.56% |
| Oct 31, 2020 | 5.05% |
| Jul 31, 2020 | 8.99% |
| Apr 30, 2020 | -2.85% |
| Jan 31, 2020 | -3.44% |
| Oct 31, 2019 | 8.19% |
| Jul 31, 2019 | 26.95% |
| Apr 30, 2019 | 6.15% |
| Jan 31, 2019 | -18.34% |
| Oct 31, 2018 | 181.27% |
| Jul 31, 2018 | 23.49% |
| Apr 30, 2018 | -1.40% |
| Jan 31, 2018 | 4.40% |
| Oct 31, 2017 | 23.53% |
| Jul 31, 2017 | 33.13% |
| Apr 30, 2017 | 3.11% |
| Jan 31, 2017 | 155.56% |
| Oct 31, 2016 | 1,475.00% |
| Mar 31, 2016 | 7.92% |
| Dec 31, 2015 | 17.99% |
| Sep 30, 2015 | 681.08% |
| Jun 30, 2015 | -68.64% |
| Sep 30, 2014 | 100.00% |
| Jun 30, 2014 | -15.25% |